US Patent Issued to MTI Biotech on Aug. 12 for "Compositions and methods of use of Gamma-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liver" (Iowa, Tennessee Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,515, issued on Aug. 12, was assigned to MTI Biotech Inc. (Ames, Iowa).

"Compositions and methods of use of Gamma-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liver" was invented by John Rathmacher (Story City, Iowa), Naji Abumrad (Nashville, Tenn.) and Charles Flynn (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for use in treating, preventing or improving diseases related to the liver in an animal, including but not limited to nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) or nonalcoho...